Meet the Team
Louis Metzger, PhD
Co-Founder & CEO
21 years’ research experience; 13 years in industry, 6 years in senior management and leadership roles
Zibo Li, PhD
Co-Founder & COO
24 years’ research experience; 17 years on cGMP, 10 years as cyclotron and radiochem program director
Anthony Casarez, PhD
Co-Founder & CSO
23 years’ research experience; 15 years in industry, 6 years in senior leadership roles
David Nicewicz, PhD
Co-Founder & CTO
23 years’ research experience; 23 years in academia, co-founder of two companies
Nima Kokabi, MD, FRCPC
Chief Medical Officer
22 years’ medical and research experience; Dir. of Interventional Oncology and Dir. of Cancer Imaging, UNC; PI of 4 ongoing targeted radiotherapy clinical trials
Our Scientific Advisory Board
Phillip Kuo, MD, PhD
Leading nuclear oncology physician, radiologist, and medical researcher
Practitioner at the forefront of nuclear medicine for 20 years; designed the read rules for the Pluvicto™ VISION trial
Heinz Moser, PhD
Industry leader in small molecule drug design and development
Site Head of Global Discovery Chemistry and Executive Director at Novartis Emeryville California (retired); former VP of Chemistry at Achaogen; former CTO and VP of Chemistry at GeneSoft
David Morris, MD
Pharma and biotech executive, VC, physician-scientist
Vice Chancellor for Business Development, Innovation and Partnerships at UCSF; former Global Head of Clinical Operations, Novartis; former Managing Director of Novartis Venture Fund; former Head of R&D, Valo Health; former CMO, Enterprise Therapeutics